Press Contact
For media enquiries, please reach out to: contact@aspivix.com
All
- All
- Blog
- In the media
- Press releases
Will This Antiquated Gynecological Tool Get an Upgrade?
The tenaculum might contribute to the discomfort women feel when getting an IUD. One company is testing an alternative. A growing number of women have opted to get an intrauterine device in...
First Successful IUD and Transcervical Procedures with Aspivix’s Non-Traumatic Carevix® Performed in the US
The first successful IUD and transcervical procedures using Aspivix's non-traumatic carevix® were performed in the U.S. This milestone underscores the potential of carevix® to offer a gentler alternative to traditional methods. The procedures...
Innovative cervical device used for first time in US gynaecological procedures
The Swiss-based start-up Aspivix has announced the first gynaecological procedures performed with its innovative cervical device in the US. The product, a suction-based cervical device known as carevix®, aims to reduce pain and...
Revolutionizing Women’s Healthcare: An Innovative Journey with Aspivix
ASPIVIX announced its collaboration with Bayer Switzerland to enhance women’s healthcare. This partnership aims to introduce carevix®, a CE-marked and FDA-cleared cervical stabilizer designed to transform gynaecological procedures, reducing pain and bleeding...
Bayer to accelerate adoption of Aspivix’s medical device
Millions of women worldwide experience pain during an Intrauterine Contraceptive Device insertion with traditional cervical tenaculum used in gynecological procedures. Aspivix' carevix® device is a gentler alternative. The startup has joined forces...
Bayer and ASPIVIX collaborate on women’s health device
ASPIVIX announces its partnership with Bayer (Schweiz) in Switzerland, aimed at transforming gynecological procedures. The companies are introducing carevix®, a CE-Marked cervical stabiliser designed to minimise pain and bleeding during transcervical procedures,...
